Review · 2020
Placebo and Nocebo Effects
Colloca L, Barsky AJ
The New England Journal of Medicine, 2020 · PMID 32023375
In short
A general-medicine review of proposed mechanisms behind placebo and nocebo responses, including expectation, conditioning and the clinical encounter itself.
- Study type
- Review
- Published
- The New England Journal of Medicine, 2020
- Topics
- Nocebo, Mechanisms, Clinical practice
placebo and nocebo effects explained?
Placebo and nocebo are the same machinery running in opposite directions: expectation, conditioning and context can produce real symptom improvement (placebo) or real side effects (nocebo). This 2020 review is the standard clinical overview of how both arise and why they matter for interpreting any trial.
Placebo research is not only about improvement. Nocebo — where negative expectation produces negative symptoms — is the same machinery running the other direction, and it explains a meaningful share of reported side effects.
The question
What mechanisms have researchers proposed for placebo and nocebo responses, and what do they mean for everyday clinical practice?
How it was done
- Narrative review of experimental, neuroimaging and clinical literature.
- Covers expectancy, classical conditioning, learning, and the influence of communication and context.
- Discusses how nocebo responses arise from informed-consent language and side-effect warnings.
What was reported
- Placebo and nocebo responses are described as measurable psychobiological phenomena rather than the absence of an effect.
- Context, framing and the clinician relationship are presented as active parts of any treatment.
- The review discusses ethical considerations, including open-label approaches that avoid deception.
Limitations
- A narrative review, not a quantitative synthesis, so it does not produce pooled effect estimates.
- Mechanistic accounts remain proposals under active investigation.
Why it matters
It is the best single entry point for understanding why placebo controls exist and why nocebo matters as much as placebo when interpreting trial results.
Citation
Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382(6):554–561.
PMID 32023375This summary is written by Efficacy Labs and is not a substitute for the original publication. The research described here is independent work by third parties and was not conducted using Efficacy Labs products. Efficacy Labs products contain no active therapeutic ingredient and are not intended as substitutes for prescribed medication or professional medical care. Information on this website is provided for general educational and research purposes and is not medical advice. References to published research describe independent scientific literature and do not imply that the research was conducted using Efficacy Labs products unless explicitly stated.
Background
What the placebo effect is, explained simply
How the effect is defined, what researchers think drives it, and how it is measured in trials like this one.
Products
Placebo pills for research and education
Inert capsules from Efficacy Labs, what they contain, and how to order them for a study or a classroom.
Continue reading
Randomized controlled trial
Open-label placebo in IBS (2010)
The trial that started modern open-label placebo research: patients were openly told their pills were inert placebos, and were still assessed against a no-treatment control.
Randomized controlled trial
Open-label placebo in chronic low back pain (2016)
An open-label placebo added on top of patients' existing treatment as usual for chronic low back pain, tested over three weeks in Portugal.
Randomized controlled trial
Open-label placebo and cancer-related fatigue (2018)
Cancer survivors with persistent fatigue took openly labelled placebo pills for three weeks alongside their usual care.